Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Nov 23:10:1305791.
doi: 10.3389/fmed.2023.1305791. eCollection 2023.

Editorial: Secondary hyperparathyroidism: an ongoing challenge for the nephrologist

Claudia Torino  1 , Rocco Tripepi  1 , Domenico Russo  2 , Antonio Demetrio Vilasi  1 , Vincenzo Antonio Panuccio  3
Affiliations
Editorial

Editorial: Secondary hyperparathyroidism: an ongoing challenge for the nephrologist

Claudia Torino et al. Front Med (Lausanne). .
No abstract available

Keywords: ESRD; chronic kidney disease; hyperparathyroidism; nephrology; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Figures

Figure 1
Figure 1
Secondary hyperparathyroidism: treatment, risk factors, and complications. See the text for more details. Image sources are: Image at the center of the figure: Reprinted with permission from RMHare, licensed under CC0 1.0, https://commons.wikimedia.org/wiki/File:Doctor_showing_form.jpg. Parathyroidectomy: Reprinted with permission from BennyK95, work in the Public Domain, https://commons.wikimedia.org/wiki/File:RightFemurII.JPG. Radiofrequency ablation: Reprinted with permission from Scientific Animations (https://www.scientificanimations.com/wiki-images/), licensed under CC BY-SA 4.0, https://www.scientificanimations.com/wp-content/uploads/2018/06/Radiofrequency-ablation.jpg. Pharmacological therapy: Reprinted with permission from Figure 2 of “Evocalcet: A New Oral Calcimimetic for Dialysis Patients With Secondary Hyperparathyroidism” by Akizawa et al., licensed under CC BY-NC 4.0, https://doi.org/10.1111/1744-9987.13434. Biomarkers of mineral bone disorder: Reprinted with permission from Hbf878 (https://commons.wikimedia.org/wiki/User:Hbf878), licensed under CC0 1.0, https://commons.wikimedia.org/wiki/File:Vitamin_D_biosynthesis_in_fungi_and_animals.svg. Calcium and Phosphate image: Reprinted with permission from Hoa112008, work in the Public Domain, https://commons.wikimedia.org/wiki/File:Tricalcium-phosphate-3D-balls-ionic.png. Impact on graft loss: Reprinted with permission from Schomynv (https://commons.wikimedia.org/wiki/User:Schomynv), work in the Public Domain, https://commons.wikimedia.org/wiki/File:Kidney_with_THI.jpg.
See this image and copyright information in PMC

Comment on

  • Editorial on the Research Topic Secondary hyperparathyroidism: an ongoing challenge for the nephrologist

References

    1. Bozic M, Diaz-Tocados JM, Bermudez-Lopez M, Forné C, Martinez C, Fernandez E, et al. . Independent effects of secondary hyperparathyroidism and hyperphosphataemia on chronic kidney disease progression and cardiovascular events: an analysis from the NEFRONA cohort. Nephrol Dial Transp. (2022) 37:184. 10.1093/ndt/gfab184 - DOI - PubMed
    1. Jean G, Souberbielle JC, Chazot C. Vitamin D in chronic kidney disease and dialysis patients. Nutrients. (2017) 9:328. 10.3390/nu9040328 - DOI - PMC - PubMed
    1. Jadoul M, Albert JM, Akiba T, Akizawa T, Arab L, Bragg-Gresham JL, et al. . Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the dialysis outcomes and practice patterns study. Kidney Int. (2006) 70:1358–66. 10.1038/sj.ki.5001754 - DOI - PubMed
    1. Torres A, Lorenzo V, Hernández D, Rodríguez JC, Concepción MT, Rodríguez AP, et al. . Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH. Kidney Int. (1995) 47:1434–42. - PubMed
    1. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. (2004) 15:1–2. 10.1097/01.ASN.0000133041.27682.A2 - DOI - PubMed

Publication types

LinkOut - more resources